{"id":815,"date":"2026-09-01T19:07:33","date_gmt":"2026-09-01T19:07:33","guid":{"rendered":"https:\/\/nhdbio.com\/resources\/hexarelin-human-dose-response-growth-hormone-evidence\/"},"modified":"2026-09-08T07:30:41","modified_gmt":"2026-09-08T07:30:41","slug":"hexarelin-human-dose-response-growth-hormone-evidence","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/es\/hexarelin-human-dose-response-growth-hormone-evidence\/","title":{"rendered":"Evidencia humana de hexarelina: respuesta a la dosis, pico y l\u00edmites de GH"},"content":{"rendered":"
Hexarelin tiene datos controlados de farmacolog\u00eda humana, pero la evidencia central es un experimento de dosis-respuesta 12-persona GH aguda en lugar de un ensayo de resultados cl\u00ednicos.<\/p>
Evidencia de un vistazo<\/h2>
Doce hombres sanos recibieron placebo y 0.5, 1 y 2 \u00b5g\/kg de hexarelina intravenosa en un estudio doble ciego de dosis creciente.<\/li>
El pico medio de GH fue 3.9, 26.9, 52.3 y 55.0 ng\/mL, con una meseta de respuesta entre 1 y 2 \u00b5g\/kg.<\/li>
GH alcanz\u00f3 su punto m\u00e1ximo aproximadamente en los minutos 30, volvi\u00f3 al valor inicial en los minutos 240 y tuvo una vida media estimada cercana a los minutos 55.<\/li><\/ul><\/div><\/div>Ilustraci\u00f3n editorial generada por AI que ilustra el flujo de trabajo de la investigaci\u00f3n. No es una figura de estudio, una imagen de un paciente, una fotograf\u00eda de un producto, un resultado de un ensayo ni un lote de cat\u00e1logo.<\/figcaption><\/figure>
Registro de estudio<\/h2>
El estudio 1994 insert\u00f3 placebo al azar en la secuencia de dosis creciente. Los picos medios casi id\u00e9nticos en 1 y 2 \u00b5g\/kg son un hallazgo de meseta \u00fatil y no deben reescribirse como \u201ccuanto m\u00e1s alto, siempre mejor\u201d.<\/p>
Dise\u00f1o<\/strong>Doble ciego, controlado con placebo, de dosis creciente<\/span><\/div>
Media GH Cm\u00e1x<\/strong>3.9, 26.9, 52.3 y 55.0 ng\/mL<\/span><\/div>
ED50 estimado<\/strong>0.50 \u00b5g\/kg por Cm\u00e1x; 0.64 \u00b5g\/kg por AUC<\/span><\/div>
L\u00edmite de resultados<\/strong>Liberaci\u00f3n aguda de hormonas, no enfermedad, longevidad o beneficio de rendimiento<\/span><\/div><\/div><\/div>
Resultados en contexto<\/h2>
Un estudio posterior con seis personas compar\u00f3 dos versus tres administraciones subcut\u00e1neas diarias mientras se monitoreaba GH, prolactina, ACTH y cortisol durante horas 24. M\u00faltiples cambios endocrinos refuerzan que Hexarelin no puede reducirse a un reclamo selectivo de GH \u00fanicamente.<\/p>
WADA incluye Examorelin\/Hexarelin entre los p\u00e9ptidos liberadores de GH prohibidos. Esa clasificaci\u00f3n es relevante para el deporte pero no establece la eficacia ni la identidad del producto.<\/p>
Lo que la evidencia no puede establecer<\/h2>
El ensayo principal cont\u00f3 con participantes varones sanos 12 y criterios de valoraci\u00f3n agudos.<\/p>
No se midieron resultados de composici\u00f3n corporal, recuperaci\u00f3n, enfermedad o seguridad a largo plazo.<\/p>
La respuesta endocrina de un material experimental definido no puede validar un lote de cat\u00e1logo.<\/p>","protected":false},"excerpt":{"rendered":"
Hexarelin tiene datos controlados de farmacolog\u00eda humana, pero la evidencia central es un experimento de dosis-respuesta 12-persona GH aguda en lugar de un ensayo de resultados cl\u00ednicos.<\/p>","protected":false},"author":1,"featured_media":799,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"336","pim_article_type":"Published evidence review","pim_evidence_level":"Double-blind 12-person dose-response trial plus small repeated-exposure physiology study","pim_reviewer":"Site evidence editorial team","pim_reviewed_date":"2026-09-02","pim_editorial_note":"Source-checked on 2026-09-02. Null results, sample size, model\/population limits, finished-drug scope, regulatory status and product-evidence boundaries are retained. This is not medical advice, a customer case or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"Primary and official sources, numerical results, null findings, limitations, product-evidence boundary and image disclosure checked for batch 5.","pim_creation_method":"This article discusses the source records listed below, with the study models and limitations stated alongside the findings. AI-assisted drafting and image generation were used. The reference list identifies the records behind this article; it is not an independent peer review or verification of a supplied catalog lot.","pim_sources":"[{\"title\":\"Hexarelin human dose-response study\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/7957536\/\",\"note\":\"Double-blind 12-person study; PMID 7957536.\"},{\"title\":\"Repeated Hexarelin administration in healthy men\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/11888836\/\",\"note\":\"Six-person 24-hour endocrine study; PMID 11888836.\"},{\"title\":\"PubChem Examorelin record\",\"url\":\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Examorelin\",\"note\":\"Sequence, formula, molecular weight and synonyms; CID 6918297.\"},{\"title\":\"WADA 2026 Prohibited List\",\"url\":\"https:\/\/www.wada-ama.org\/sites\/default\/files\/2025-09\/2026list_en_final_clean_september_2025.pdf\",\"note\":\"Official list includes Examorelin\/Hexarelin.\"}]","footnotes":""},"categories":[19],"tags":[],"class_list":["post-815","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-published-study-cases"],"yoast_head":"\n
Hexarelin Human Evidence: Dose Response, GH Peak and Limits<\/title>\n<meta name=\"description\" content=\"Hexarelin has controlled human pharmacology data, but the central evidence is an acute 12-person GH dose-response experiment rather than a clinical-outcome\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/es\/hexarelin-human-dose-response-growth-hormone-evidence\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hexarelin Human Evidence: Dose Response, GH Peak and Limits\" \/>\n<meta property=\"og:description\" content=\"Hexarelin has controlled human pharmacology data, but the central evidence is an acute 12-person GH dose-response experiment rather than a clinical-outcome\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/es\/hexarelin-human-dose-response-growth-hormone-evidence\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-01T19:07:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-08T07:30:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/hexarelin-evidence.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Hexarelin Human Evidence: Dose Response, GH Peak and Limits\",\"datePublished\":\"2026-09-01T19:07:33+00:00\",\"dateModified\":\"2026-09-08T07:30:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/\"},\"wordCount\":270,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/hexarelin-evidence.webp\",\"articleSection\":[\"Published Study Reviews\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/\",\"name\":\"Hexarelin Human Evidence: Dose Response, GH Peak and Limits\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/hexarelin-evidence.webp\",\"datePublished\":\"2026-09-01T19:07:33+00:00\",\"dateModified\":\"2026-09-08T07:30:41+00:00\",\"description\":\"Hexarelin has controlled human pharmacology data, but the central evidence is an acute 12-person GH dose-response experiment rather than a clinical-outcome\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/hexarelin-evidence.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/hexarelin-evidence.webp\",\"width\":1536,\"height\":1024,\"caption\":\"AI-generated illustration: clinical pharmacology laboratory for a Hexarelin evidence review\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hexarelin Human Evidence: Dose Response, GH Peak and Limits\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/es\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Evidencia humana de hexarelina: respuesta a la dosis, pico y l\u00edmites de GH","description":"Hexarelin ha controlado los datos de farmacolog\u00eda humana, pero la evidencia central es un experimento agudo de dosis-respuesta 12-persona GH en lugar de un resultado cl\u00ednico...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/es\/hexarelin-human-dose-response-growth-hormone-evidence\/","og_locale":"es_ES","og_type":"article","og_title":"Hexarelin Human Evidence: Dose Response, GH Peak and Limits","og_description":"Hexarelin has controlled human pharmacology data, but the central evidence is an acute 12-person GH dose-response experiment rather than a clinical-outcome\u2026","og_url":"https:\/\/nhdbio.com\/es\/hexarelin-human-dose-response-growth-hormone-evidence\/","og_site_name":"NHD","article_published_time":"2026-09-01T19:07:33+00:00","article_modified_time":"2026-09-08T07:30:41+00:00","og_image":[{"width":1536,"height":1024,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/hexarelin-evidence.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Escrito por":"NHD Technical Team","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Hexarelin Human Evidence: Dose Response, GH Peak and Limits","datePublished":"2026-09-01T19:07:33+00:00","dateModified":"2026-09-08T07:30:41+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/"},"wordCount":270,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/hexarelin-evidence.webp","articleSection":["Published Study Reviews"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/","url":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/","name":"Evidencia humana de hexarelina: respuesta a la dosis, pico y l\u00edmites de GH","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/hexarelin-evidence.webp","datePublished":"2026-09-01T19:07:33+00:00","dateModified":"2026-09-08T07:30:41+00:00","description":"Hexarelin ha controlado los datos de farmacolog\u00eda humana, pero la evidencia central es un experimento agudo de dosis-respuesta 12-persona GH en lugar de un resultado cl\u00ednico...","breadcrumb":{"@id":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/hexarelin-evidence.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/hexarelin-evidence.webp","width":1536,"height":1024,"caption":"AI-generated illustration: clinical pharmacology laboratory for a Hexarelin evidence review"},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Hexarelin Human Evidence: Dose Response, GH Peak and Limits"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Materias primas pept\u00eddicas y s\u00edntesis personalizada","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"Equipo t\u00e9cnico de NHD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"El equipo t\u00e9cnico de NHD mantiene documentaci\u00f3n del cat\u00e1logo de uso de investigaci\u00f3n y res\u00famenes de evidencia. Los art\u00edculos revisados \u200b\u200benlazan con art\u00edculos revisados \u200b\u200bpor pares, registros de ensayos y registros regulatorios, conservan hallazgos nulos y limitaciones de estudios, y distinguen las intervenciones publicadas de los materiales del cat\u00e1logo. Se puede utilizar dibujo asistido por AI para la estructura; los enlaces de fuentes y los l\u00edmites de las pruebas permanecen visibles. Este trabajo no es una revisi\u00f3n por pares independiente ni un consejo m\u00e9dico.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/es\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/815","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/comments?post=815"}],"version-history":[{"count":2,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/815\/revisions"}],"predecessor-version":[{"id":1188,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/815\/revisions\/1188"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media\/799"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media?parent=815"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/categories?post=815"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/tags?post=815"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"Laboratorio](\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/hexarelin-evidence.webp\")